Catalyst Wire Dossier Catalyst Wire Dossier

NETrin MAbs

· NETRIS Pharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NETrin MAbs, covering 2024-10-08 to 2024-10-08. Get the full timeline:

Most recent: Clinical Trial Update: GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab [Phase 1, Phase 2]

See pricing